Biocon Biologics

Biocon Biologics Business

Biocon Biologics secures market entry for Yesafili in US

Biocon Biologics on Tuesday said it has inked a settlement and licensing pact with Regeneron, paving the way to commercialise its biosimilar product Yesafili ...

By NewsDrum Desk
Apr 15, 2025 10:49 IST 2 Min read
Biocon Biologics Business
Biocon Biologics gets USFDA approval for cancer biosimilar
By NewsDrum Desk
Apr 10, 2025 13:14 IST 1 Min read
Biocon Biologics Business
Biocon settles with Janssen to commercialise biosimilar products in Europe, Canada, Japan
By NewsDrum Desk
Aug 29, 2024 11:34 IST 2 Min read
Biocon Biologics Business
Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant
By NewsDrum Desk
Jun 24, 2024 12:54 IST 1 Min read
Biocon Biologics Business
Biocon Biologics secures USFDA approval for biosimilar product to treat ophthalmology conditions
By NewsDrum Desk
May 21, 2024 12:04 IST 1 Min read
Biocon Biologics Business
Eris acquires commercial rights of Biocon Biologics' India branded formulations biz for Rs 1,242 cr
By NewsDrum Desk
Mar 14, 2024 17:42 IST 2 Min read
Biocon Biologics Business
Biocon Biologics settles patent issue; paves way for launch of biosimilar product in Canada
By NewsDrum Desk
Mar 04, 2024 11:27 IST 1 Min read
serum institute of india.jpg Business
Serum to pump in additional USD 150 mn in Biocon Biologics
By NewsDrum Desk
Apr 25, 2023 15:30 IST 1 Min read
biocon-biologics-logo Business
USFDA issues CRL for proposed biosimilar Insulin-R: Biocon
By NewsDrum Desk
Jan 07, 2023 14:55 IST 1 Min read
1 2 ... Next